![glp 1 action Glucagon-like peptide-1 glp-1_analogs [TUSOM | Pharmwiki]](https://upload.wikimedia.org/wikipedia/commons/6/64/Incretins_and_DPP_4_inhibitors.svg)
glp 1 action Glucagon-like peptide-1 glp-1_analogs [TUSOM | Pharmwiki]
Description
Learn why some patients cannot tolerate these medications and when endoscopic sleeve may be considered.
![glp 1 action Glucagon-like peptide-1 glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
Therefore, further research is necessary to fully understand the potential of GLP-1 receptor agonists in providing comprehensive protection against complications related to T2DM.
![glp 1 action Glucagon-like peptide-1 glp-1_analogs [TUSOM | Pharmwiki]](https://s3.amazonaws.com/production.scholastica/public/attachments/9c499677-aa6b-4e1e-9360-4d7e41721fd8/figure_1._mechanism_of_synthesis_of_glp-1.png)
For example, semaglutide and empagliflozin showed no significant difference in 3-point MACE (HR 1.05
![glp 1 action Glucagon-like peptide-1 glp-1_analogs [TUSOM | Pharmwiki]](https://drsobo.com/wp-content/uploads/2025/04/Screenshot-2025-04-18-144401.jpg)
FDA-Approved Indications GLP-1 agonists (also known as GLP-1 receptor agonists, incretin mimetics, or GLP-1 analogs) represent a class of medications used to treat T2DM and, in some cases,
![glp 1 action Glucagon-like peptide-1 glp-1_analogs [TUSOM | Pharmwiki]](https://www.teachmepharmacy.info/wp-content/uploads/2025/10/AdobeStock_577004646-scaled.jpeg)
